Antibody Testing for Autoimmune Neurological Disorders: Which Tests to Order and Why?

Pankaj Kumar, Ali Mousavi, and Hans Frykman. Antibody Testing for Autoimmune Neurological Disorders: Which Test/s to Order and Why? AACC Academy Scientific Shorts. November 22, 2022, Available from: https://www.aacc.org/science-and-research/scientific-shorts/2022/antibody-testing-for-autoimmune-neurological-disorders-which-tests-to-order-and-why

An Opinion on the Clinical Laboratory Testing following the New 2021 PNS-Care Diagnostic Criteria

Frykman, H, Kumar, P.  An Opinion on the Clinical Laboratory Testing following the New 2021 PNS-Care Diagnostic Criteria, The Journal of Applied Laboratory Medicine, Volume 7, Issue 1, January 2022, Pages 367–372, https://doi.org/10.1093/jalm/jfab154

Laboratory Testing of Myasthenia Gravis: New Treatments Drive Change

Frykman, H, Kumar, P.  Laboratory Testing of Myasthenia Gravis: New Treatments Drive Change, The Journal of Applied Laboratory Medicine, , jfaa199, https://doi.org/10.1093/jalm/jfaa199

Immunopathology of Autoimmune Myasthenia Gravis: Implications for Improved Testing Algorithms and Treatment Strategies

Frykman, H, Kumar, P, Oger, J.  Immunopathology of Autoimmune Myasthenia Gravis: Implications for Improved Testing Algorithms and Treatment Strategies.  Front. Neurol., 09 December 2020 | https://doi.org/10.3389/fneur.2020.596621

An Update on Laboratory Diagnosis in Myasthenia Gravis

Oger J, Frykman H. 2015 Sep 20;449:43-8.  doi:10.1016/j.cca.2015.07.030.

Detection of anti-natalizumab antibodies in treated multiple sclerosis patients using a BIAcore™ platform

Fronda A, Gibbs E, Aziz T, Oger J (2014).  Detection Of Anti-Natalizumab Antibodies In Treated Multiple Sclerosis Patients Using a Biacore™ Platform (P4.139).   Neurology Apr 2014, 82 (10 Supplement) P4.139;

NMO-IgG as Measured in Multiple Facilities in Optic Neuritis (ON), Transverse Myelitis and Combinations Thereof

Fronda A, Kuan A, Fritzler M, Fujihara K, Takahashi T. (2012). NMO-IgG as Measured in Multiple Facilities in Optic Neuritis (ON), Transverse Myelitis (TM) and Combinations Thereof (P02.130). Neurology. 78. P02.130-P02.130. 10.1212/WNL.78.1_MeetingAbstracts.P02.130.

Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis

Spagni G, Gastaldi M, Businaro P, Chemkhi Z, Carrozza C, Mascagna G, Falso S, Scaranzin S, Franciotta D, Evoli A, Damato V. Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis. Neurology-Neuroimmunology Neuroinflammation. 2023 Jan 1;10(1). Available from: https://nn.neurology.org/content/10/1/e200038

A Multicenter Comparison of MOG-IgG Cell-Based Assays

Waters PJ, Komorowski L, Woodhall M, et al. A multicenter comparison of MOG-IgG cell-based assays. Neurology. 2019;92(11):e1250‐e1255. doi:10.1212/WNL.0000000000007096

Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder

Pittock SJ, Berthele A, Fujihara K, et al. Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder. N Engl J Med. 2019;381(7):614‐625. doi:10.1056/NEJMoa1900866

Live-cell Based Assays Are the Gold Standard for anti-MOG-Ab Testing

Yeh EA, Nakashima I. Live-cell based assays are the gold standard for anti-MOG-Ab testing. Neurology. 2019;92(11):501‐502. doi:10.1212/WNL.0000000000007077

MOG Encephalomyelitis: International Recommendations on Diagnosis and Antibody Testing

Jarius S, Paul F, Aktas O, et al. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation. 2018;15(1):134. Published 2018 May 3. doi:10.1186/s12974-018-1144-2

Multicentre Comparison of a Diagnostic Assay: Aquaporin-4 Antibodies in Neuromyelitis Optica

Waters P, Reindl M, Saiz A, et al. Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica. J Neurol Neurosurg Psychiatry. 2016;87(9):1005‐1015. doi:10.1136/jnnp-2015-312601

Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis

Rodríguez Cruz PM, Al-Hajjar M, Huda S, et al. Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis. JAMA Neurol. 2015;72(6):642‐649. doi:10.1001/jamaneurol.2015.0203

Evaluation of aquaporin-4 antibody assays

Waters PJ, Pittock SJ, Bennett JL, Jarius S, Weinshenker BG, Wingerchuk DM. Evaluation of aquaporin-4 antibody assays. Clin Exp Neuroimmunol. 2014;5(3):290‐303. doi:10.1111/cen3.12107

Clinical and Serological Study of Myasthenia Gravis Using Both Radioimmunoprecipitation and Cell-Based Assays in a South Asian Population

Chang T, Leite MI, Senanayake S, et al. Clinical and serological study of myasthenia gravis using both radioimmunoprecipitation and cell-based assays in a South Asian population. J Neurol Sci. 2014;343(1-2):82-87. doi:10.1016/j.jns.2014.05.037

Late-onset myasthenia gravis: A review when incidence in older adults keeps increasing.

Alkhawajah NM, Oger J. Muscle Nerve. 2013 Nov;48(5):705-10. doi: 10.1002/mus.23964.